Founded in 2018, SomaServe was spun out of UCL with the mission to build a uniquely-positioned pharma service and specialist reagent business exploiting PolyNaut® technology to image live cells and improve the therapeutic viability of molecules with poor pharmacokinetic and chemical properties.